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Abstract
Objective This study aims to evaluate the treatment effect of a mindfulness-based intervention for Chinese breast cancer patients
across outcome domains, including symptom-related, psychosocial, and quality of life outcomes.
Methods Following the Cochrane Systematic Review guideline, we searched across five electronic databases, reference lists of
eligible studies, professional websites, and major academic journals in Chinese. Publication bias was assessed using funnel plot
and Vevea and Woods sensitivity analysis, and risk of bias was evaluated using the revised Cochrane risk of bias tool for
randomized trials and risk of bias in non-randomized studies of interventions. A meta-analysis of Hedges’ g was conducted
using meta-regression with robust variance estimation.
Results Final analysis included a total of 45 controlled trials containing 286 effect size estimates. Across outcome domains,
studies reported an overall large and statistically significant treatment effect, d = 0.921, 95% CI (0.805, 1.040), p < 0.001.
Subgroup analyses of specific domains of outcome reported overall significant treatment effects for (1) symptom-related out-
comes, d = 0.885, 95% CI (0.657, 1.110), p < 0.001; (2) psychosocial wellness outcomes, d = 0.984, 95% CI (0.879, 1.090), p <
0.001; and (3) quality of life, d = 0.990, 95% CI (0.776, 1.200), p < 0.001. Moderator analysis did not identify any significant
moderator.
Conclusion Chinese literature reported an overall statistically significant and large treatment effect of a mindfulness-based
intervention for breast cancer patients in China. Except for physical symptom outcomes, e.g., nausea/vomiting and pain, a
mindfulness-based intervention was effective across outcome domains among Chinese breast cancer patients.
Keywords Breast cancer .Mindfulness-based intervention . Systematic review andmeta-analysis
Breast cancer is the most common cancer and cause of cancer-
related death among women internationally [1]. There were
over 2 million newly diagnosed breast cancer patients
worldwide in 2018, including 626,679 associated deaths [2].
Medical treatments for breast cancer have advanced significant-
ly over the past decade, resulting in major improvements in
breast cancer patients’ 5-year survival rate [3–5]. However,
psychosocial and symptom-related outcomes among breast
cancer patients remain poorly addressed both during and after
patients’ cancer treatment [6–8]. Breast cancer patients,
especially those receiving ongoing treatment, often suffer from
physical side effects such as nausea/vomiting, sleep disturbance,
chronic pain, shortness of breath, among others [9, 10]. Although
most of these physical symptoms are prominent during active
cancer treatment, many patients continue to endure physical late
effects for many years after treatment completion [11, 12].
Additionally, breast cancer patients often encounter a high
level of psychosocial challenges throughout their disease tra-
jectory including, but not limited to, depression, anxiety,
mood disorders, and psychological distress [13–15]. Meta-
analyses of the global prevalence of psychiatric disorders
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revealed an average rate of 32.2% and 41.9% for breast cancer
patients, respectively [16, 17]. Notably, rates of depression
and anxiety among breast cancer patients were reported at
least two times higher in developing countries than developed
countries, underscoring the mental health disparities and un-
met psychosocial needs among breast cancer patients from
developing countries.
Finally, unaddressed physical symptoms and psychosocial
challenges may lead to patients’ compromised wellbeing such
as decreased self-efficacy, increased risk of substance use, and
reduced quality of life. For example, studies have found that
breast cancer patients’ quality of life was the lowest before
postoperative chemotherapy, increased after the second che-
motherapy, then lowered again after the fourth and fifth
rounds of chemotherapy [18]. The quality of life trajectory
among breast cancer patients continues to fluctuate through-
out their post-treatment survivorship care, highlighting the
needs for ongoing surveillance and interventions to address
breast cancer patients’ biopsychosocial challenges [19].
Therefore, it is essential for health and mental health providers
to have a thorough understanding of existing psychosocial
interventions to support breast cancer patients.
Mindfulness-based interventions for breast
cancer patients
Mindfulness-based interventions represent a unique form of
psychotherapeutic and/or supportive intervention that war-
rants attention for cancer patients, including those diagnosed
with breast cancer. In this study, a mindfulness-based inter-
vention is defined as any form of psychotherapeutic and/or
supportive intervention that uses mindfulness as the core treat-
ment component. This study operationalizes mindfulness
using two features: (1) mindfulness grounds attention and
awareness in one’s present moment experience and (2) mind-
fulness posits that adopting an attitude of openness or accep-
tance toward one’s experience is critical [20]. Unlike most
didactic psychotherapies (e.g., cognitive behavioral therapy
or problem-solving therapy), mindfulness-based interventions
do not have a structured change process/mechanism but, in-
stead, focus on attention to the present, acceptance, and emo-
tion regulation [21, 22]. This is particularly important for can-
cer patients because many didactic psychotherapies do not
sufficiently address patients’ cognitive structure and emotion-
al response to a cancer diagnosis and its treatment [22–24].
When facing a cancer diagnosis, many cognitive patterns and
emotional responses generally considered maladaptive are
now normalized. For example, fear of death is typically con-
sidered as an irrational or exaggerated thought for most indi-
viduals who have health and/or death anxiety. However, fear
of death is a reasonable and expected thought among breast
cancer patients. As a result, traditional approaches of
“modifying” or “intervening” fear of death would not work
effectively among cancer patients. On the other hand,
mindfulness-based interventions focusing on acceptance and
emotion regulation when facing distressful thoughts and emo-
tions, like death anxiety, may effectively target cancer pa-
tients’ concerns. Finally, changes in body image, self-percep-
tion, and sexuality among breast cancer patients also highlight
the unique relevance of mindfulness-based interventions that
focus on acceptance, inner reflection, and emotion regulation.
In summary, mindfulness-based interventions provide a
mechanism of change that addresses the unique physical and
psychosocial challenges experienced by women with breast
cancer. It is essential for psycho-oncology providers, e.g.,
cancer psychologists, oncology social workers, and oncology
nurses, to better understand the effectiveness of mindfulness-
based interventions for breast cancer patients.
Existing reviews and gap in the literature
To our knowledge, seven systematic reviews and/or meta-
analysis studies published in English focused on
mindfulness-based interventions for breast cancer patients.
Specifically, four studies [25–28] focused on Mindfulness-
Based Stress Reduction for breast cancer patients’ psycholog-
ical outcomes, quality of life, and symptom-related outcomes.
The number of included studies was small in general (2 re-
views included 3 randomized controlled trials (RCTs); 1 re-
view included 9 RCTs and 1 review included 14 RCTs). In
addition, three studies [29–31] evaluated the effectiveness of
mindfulness-based interventions for breast cancer patients’
physical, psychosocial, and quality of life outcomes. The size
of these three reviews remains relatively small with six, ten,
and seven included RCTs. Across the seven published re-
views, findings were consistent in supporting mindfulness-
based interventions for breast cancer patients across outcome
domains, i.e., symptom-related outcomes, psychosocial out-
comes, and quality of life. Most reported effect size estimates
were moderate to large ranging from d = 0.31 to d = 1.48.
However, several important gaps remain in the existing
literature. First, most published reviews included fewer than
10 studies, which reduces the level of confidence regarding
their meta-analytic findings. Second, only three out of seven
studies broadly focused on mindfulness-based interventions
and four studies narrowly focused on mindfulness-based
stress reduction. While all these reviews are highly valuable
to our understanding of mindfulness-based interventions for
breast cancer patients, research synthesis studies regarding
various mindfulness-based interventions for breast cancer pa-
tients remain limited. Third, most existing reviews focused on
a confined set of outcome domains rather than being inclusive
of physical, psychosocial, and quality of life outcomes. While
a confined review would provide greater conceptual clarity,
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most breast cancer patients suffer from a combination of
biopsychosocial challenges. Therefore, a comprehensive re-
view that includes multiple outcome domains may provide a
holistic picture for psycho-oncology providers when consid-
ering treatment options for breast cancer patients. Finally, over
80% of RCTs included in existing reviews were conducted in
developed countries, e.g., North America and Europe, which
limited their implications to developing countries as well as
racial/ethnic minority immigrants in developed countries. This
is problematic especially given the health and mental health
disparities among racial/ethnic minority breast cancer patients,
including breast cancer patients who are Chinese.
Asian Americans have the third-highest rate of breast can-
cer incidence internationally [32] and the highest rate of in-
crease in breast cancer incidence despite the overall stable
trend across racial/ethnic groups [32, 33]. Studies have con-
sistently reported disparities among Asian breast cancer pa-
tients [34], especially those pertaining to psychosocial sup-
port. Significantly greater disease burdens were identified
among Asian breast cancer patients in comparison to other
racial/ethnic groups due to poor access to evidence-based psy-
chosocial interventions [35, 36]. In other words, while there
are evidence-based psychosocial interventions for breast can-
cer patients in general, limited attention has focused on the
effectiveness of these interventions on breast cancer patients
of Chinese descendent. Most importantly, published system-
atic reviews andmeta-analysis studies (between 2012 to 2019)
identified only two clinical trials published in English deliver-
ing mindfulness-based interventions for breast cancer patients
in China, leaving few empirical evidence supporting the use of
a mindfulness-based intervention for breast cancer patients of
Chinese descendent.
Therefore, the purpose of this study is to evaluate the ef-
fectiveness of mindfulness-based intervention for breast can-
cer patients that are published in the Chinese literature.
Acknowledging the complex biopsychosocial challenges
confronting Chinese breast cancer patients, this review is in-
clusive of various domains of outcomes including physical,
psychosocial, and quality of life outcomes. Specifically, we
evaluate the following hypotheses: (1) mindfulness-based in-
terventions are overall effective for Chinese breast cancer pa-
tients and (2) explore possible factors, e.g., treatment modality
(individual versus group intervention) or treatment approach
(mindfulness as a therapeutic intervention versus as a behav-
ioral skill), moderate the treatment effect.
Methods
Search strategy A total of 5 electronic databases were
searched in this study. Three electronic databases, including
China Academic Journals Full-Text Database; China
Academic Journals Electronic Publishing House; and China
Academic Journal Network Publishing Database were
searched using the China National Knowledge Infrastructure
(CNKI). The other two datasets were (1) WanFang Data
Knowledge Service Platform which integrates over 15 types
of databases and (2) China Science and Technology Journal
Databases, which includes medical journals. The literature
search occurred on August 1, 2020, and a list of initial articles
was obtained on August 3. Search terms included “mindful-
ness” (zheng nian) or “meditation” (ming xiang) or “Zen”
(chan xiu) or “inner reflection” (nei guan) to capture
mindfulness-related studies and “breast cancer” (ru xian ai)
or “breast oncology” (ru xian liu) or “breast malignancy” (ru
xian zhong liu) to capture studies related to breast cancer.
There was no time limit for studies included in this review.
A gray literature search involved (1) screening reference lists
of eligible studies; (2) searching relevant professional
websites: China Anti-Cancer Association, Chinese Society
of Clinical oncology, and Shanghai Cancer Institute; and (3)
searchingmajor academic journals: Chinese Journal of Cancer
Research and the Chinese Journal of Cancer.
Study eligibility Studies were included if they (1) evaluated a
mindfulness-based intervention; (2) used a controlled trial
with or without random assignment; (3) targeted breast cancer
patients; (4) written and/or published in the Chinese language;
and (5) focused on physical, psychosocial, quality of life, and
mindfulness-related outcomes.
Study screening and data extraction Two independent re-
searchers utilized an Excel database to track study screening,
first based on title and abstract and then, based on full text.
Between screener, reliability was 84% for title and abstract
screening and 97% for full-text screening. When there was a
disagreement, the two reviewers met to resolve discrepancies,
and when not successful, a third reviewer read the article and
made a final decision. Study characteristics (e.g., sample size,
gender, intervention modality, outcomes) and effect size data
were extracted for each study included in the review. Study
coding followed a pre-defined coding sheet to facilitate sys-
tematic data extraction. Publication bias was visually assessed
using a funnel plot by plotting observed treatment effect size
estimates against their standard errors and then statistically
using Vevea and Woods [37] sensitivity analysis using an a
priori weight function. Risk of bias was assessed using
Version 2 of the Cochrane risk of bias tool for randomized
trials (RoB 2) [38] for randomized controlled trials and the
Risk of Bias in Non-Randomized Studies of Interventions
(ROBINS-I) [39] for controlled trials without random
assignment.
Meta-analytic procedures Data analysis used R software. In
addition to descriptive statistics describing study characteris-
tics, treatment effect size estimates were calculated for each
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individual study to determine treatment effect magnitude. All
study outcomes were continuous in nature and, therefore, ef-
fect sizes were calculated using the between-groups standard-
ized mean difference (SMD) to obtain Hedges’ g [40].
Following the best practice, we further bias corrected the g
statistic using a J function [40] to obtain an unbiased estima-
tion of treatment effect size, noted as d in this study.
Meta-analysis and moderator analysis were conducted using
meta-regression with robust variance estimation (RVE) [41,
42]. An intercept-only meta-regression model offers an overall
average of treatment effect sizes across studies. The addition of
a covariate to the meta-regression model, i.e., univariate meta-
regression, allows for evaluating the effect of potential moder-
ators on treatment effect sizes. Meta-regression is considered a
superior method than many other meta-analysis methods pri-
marily for two reasons. First, meta-regression with RVE effec-
tively handles dependent effect sizes in a meta-analysis that is
whenmore than one effect size estimates are being reported in a
study and all reported (thus dependent) effect size estimates are
being included in the meta-analysis [41, 42]. Second, meta-
regression with RVE produces robust statistical inference re-
gardless of a model’s variance modeling strategy [41, 42]. In
other words, it is not necessary to determine if a fixed- or
random-effects model is appropriate.
Results
Search results Figure 1 presents detailed steps and results of
the literature search. An initial pool of 393 articles (from both
electronic database search and manual search) was identified
for initial screening after duplicates were removed. Of the 393
articles, 266 were excluded based on title and abstract review,
resulting in 127 articles for full-text review. The full-text eval-
uation further eliminated 82 studies, leading to an analytical
sample of 45 studies including 286 effect sizes in the final
meta-analysis.
Risk of bias This was assessed using RoB 2 and ROBINS-I
[38, 39] for randomized controlled trials (RCT) and con-
trolled trials without random assignment, respectively.
Included studies overwhelmingly reported low risk of bias
(Table 1), with only one controlled trial without randomi-
zation reported moderate risk for missing data analysis and
six RCTs reported some concern for missing data analysis
and one RCT reported some concern for measurement
used.
Publication bias This was assessed using funnel plot and
Vevea and Woods sensitivity analysis using a priori weight
functions (Fig. 2). The visual inspection found the funnel plot
reasonably symmetric, which supported the absence of publi-
cation bias. Such a conclusion was further affirmed by the
Vevea and Woods sensitivity analysis. An observed line of
treatment effect size (in red) was plotted next to a theoretical
line of treatment effect size (in blue) assuming the funnel plot
is perfectly symmetric. Although the observed treatment effect
size was slightly greater than the theoretical effect size, the
difference was not statistically significant, suggesting the ab-
sence of publication bias.



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Study characteristics (Online supplemental Table 1) All in-
cluded studies were peer-reviewed articles in academic
journals, including a total of 4,280 participants. Forty-three
studies reported an average age of 46.02 years old and all were
female participants. All but one study (n = 44) focused on
breast cancer patients who were receiving active cancer treat-
ment, and 12 out of 16 studies reported participants’ cancer
stages and included breast cancer patients in both early and
middle stage of treatment. Out of the 39 studies reporting
patients’ cancer treatment, 21 (53.85%) studies reported che-
motherapy only, leaving 18 studies reporting a mixture of
chemotherapy, targeted drugs, surgery, and stem cell trans-
plant. Thirty-two studies were randomized controlled trials
and the remainder were controlled trials without random as-
signment. Twenty-two studies used individual-basedmindful-
ness interventions and 23 studies delivered mindfulness-based
interventions in a group format.
Thirty-five studies (77.78%) delivered mindfulness-based
interventions as psychotherapeutic treatments, meaning these
interventions were delivered purposefully to reduce breast
cancer patients’ psychological disorders such as depression,
anxiety, and mood disorders. Ten studies delivered
mindfulness-based interventions as supportive treatments,
meaning mindfulness was used to support breast cancer pa-
tients’ stress reduction, distress alleviation, and self-
management of disease (e.g., behavioral training). Most stud-
ies (n = 39, 86.67%) delivered mindfulness-based interven-
tions as an independent treatment, which means that mindful-
ness was the only treatment component in the intervention.
Six studies delivered mindfulness-based interventions with
mindfulness being the primary treatment component, but in
conjunction with other components, e.g., mindfulness plus
psychoeducation, or mindfulness plus behavioral modifica-
tion. Thirty-two studies utilized mindfulness as an active in-
gredient during treatment to alleviate symptoms and 13 stud-
ies taught mindfulness to participants as a method for them to












































































































































































































































































































Fig. 2 Publication bias
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Forty-one studies reported an average treatment frequency
of 11.5 sessions per month, ranging from 2 to 30 sessions
monthly. Individual session lengths averaged at 1.40 h per
session, ranging from 30 min to 2.5 h per session. Providers
of mindfulness-based interventions included mental health
professionals (e.g., psychologists, social workers, and nurses).
Sixteen studies used manualized mindfulness-based treat-
ment, whereas 29 studies did not use a treatment manual to
monitor intervention fidelity.
Treatment outcomes largely included (1) physical; (2) psy-
chosocial; and (3) quality of life. Physical outcomes included
sleep wellness-related outcomes (11 studies and 36 effect
sizes), fatigue outcomes (6 studies and 20 effect sizes), and
other types of physical symptoms (5 studies and 26 effect
sizes). Psychological wellness outcomes included depression
and anxiety (31 studies and 65 effect sizes) and other general
psychosocial outcomes (17 studies 73 effect sizes), such as
self-efficacy, and stress, among others.
Meta-analytic results (Table 2) Heterogeneity was assessed
using multi-level modeling and revealed a significant amount
of heterogeneity between effect sizes, Q (285) = 1199.53, p <
0.001. Across outcome domains, an overall treatment effect of
mindfulness-based interventions for breast cancer patients
was statistically significant, d = 0.921, 95% CI (0.805,
1.040), p < 0.001. This finding indicated a statistically signif-
icant large treatment effect of mindfulness-based interventions
for Chinese breast cancer patients. Chinese breast cancer pa-
tients receiving mindfulness-based interventions on average
are expected to report 0.921 standard deviations higher score
(i.e., improvement) than their counterparts in the treatment-as-
usual group. Subgroup analyses further indicated statistically
significant treatment effects of mindfulness-based interven-
tions for Chinese breast cancer patients to improve their (1)
symptom-related outcomes, d = 0.885, 95%CI (0.657, 1.110),
p < 0.001; (2) psychosocial wellness outcomes, d = 0.984,
95% CI (0.879, 1.090), p < 0.001; and (3) quality of life, d =
0.990, 95% CI (0.776, 1.200), p < 0.001. It was not feasible to
meta-analyze mindfulness-related outcomes because only one
study including 6 effect sizes reported this type of outcomes.
Additional subgroup analyses within symptom outcomes
and psychosocial wellness outcomes identified statistically
significant treatment effects for Chinese breast cancer pa-
tients’ sleep wellness, d = 0.939, 95% CI (0.678, 1.200), p <
0.001; fatigue, d = 1.082, 95% CI (0.833, 1.320), p < 0.001;
but not for other types of physical symptoms such as nausea,
vomiting, or pain, d = 0.589, 95% CI (− 0.212, 1.390), p =
0.111.
In addition to subgroup analyses based on outcome do-
mains, statistically significant treatment effects were observed
among other subgroups. First, an overall significant treatment
effect was observed among randomized controlled trials, d =
0.942, 95% CI (0.799, 1.080), p < 0.001 and controlled trials
without random assignment, d = 0.870, 95% CI (0.642,
1.100), p < 0.001. Second, treatment effects were statistically
significant for Chinese cancer patients receiving chemothera-
py only, d = 0.863, 95% CI (0.685, 1.040), p < 0.001 and
patients receiving multiple cancer treatments, d = 0.971,
95% CI (0.808, 1.130), p < 0.001. Thirdly, both individual-
based interventions and group-based interventions reported
overall statistically significant treatment effects, d = 0.942,
95% CI (0.768, 1.120), p < 0.001 for individual-based inter-
ventions and d = 0.901, 95% CI (0.733, 1.070), p < 0.001 for
group-based interventions. Fourth, both therapeutic and sup-
portive interventions reported statistically significant treat-
ment effects, d = 0.957, 95% CI (0.860, 1.050), p < 0.001,
and d = 0.784, 95% CI (0.353, 1.210), p < 0.001, respectively.
Finally, interventions with mindfulness as the only treatment
component reported statistically significant treatment effects,
d = 0.904, 95% CI (0.778, 1.030), p < 0.001, as well as for
interventions withmindfulness in conjunction with other treat-
ment components, d = 1.030, 95% CI (0.638, 1.430), p <
0.001
Moderator analysis and sensitivity analysis Given the signifi-
cant amount of heterogeneity among effect size estimates,
moderator analyses were conducted to evaluate if any moder-
ator explained away variances among effect sizes. Moderators
examined included (1) outcome types (symptom outcomes,
versus psychosocial wellness, versus quality of life); (2) study
design (randomized controlled trial versus controlled trials
without random assignment); (3) current treatment (chemo-
therapy only versus multiple treatment components); (4) treat-
ment modality (individual- versus group-based treatment); (5)
treatment nature (psychotherapeutic versus supportive inter-
vention); and (6) treatment integrity (independent mindfulness
only interventions versus interventions with mindfulness in
conjunction with other treatment components). Univariate
meta-regression, however, did not identify any significant
moderator. Sensitivity analyses using only studies with a
low risk of bias did not reveal any change in findings.
Therefore, only findings with the full analytical sample are
presented in this paper.
Discussion
Despite existing systematic review and meta-analysis studies
supporting the effectiveness of mindfulness-based interven-
tions for breast cancer patients, little is known about the treat-
ment effect of mindfulness-based interventions for Chinese
breast cancer patients. To our knowledge, this study is the first
systematic review and meta-analysis of Chinese literature on
mindfulness-based interventions for Chinese breast cancer pa-
tients. Across domains of outcomes, we identified an overall
large treatment effect of mindfulness-based interventions for
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breast cancer patients. Such findings were consistent with
Western literature that generally report moderate to large treat-
ment effects.
It was also encouraging that subgroup analyses overall
identified large and statistically significant treatment effects
of mindfulness-based interventions for physical, psychoso-
cial, and quality of life outcomes. When compared with
existing reviews, findings on psychosocial outcomes were
similar between Western and Chinese literature, d = 1.01
and d = 0.98, respectively. Furthermore, Chinese literature
reported overall large treatment effects for physical and qual-
ity of life outcomes (d = 0.89 and d = 0.99, respectively),
whereas Western literature reported small to moderate treat-
ment effects, d = 0.21 and d = 0.42, respectively. Although
this study did not formally evaluate the difference in treatment
effects between Western and Chinese literature for these out-
comes, it is reasonable to infer that Chinese breast cancer
patients may benefit more from mindfulness-based interven-
tions than their Western counterparts for symptom and quality
of life-related outcomes. This was possibly due to the compat-
ibility between mindfulness and Eastern culture/philosophy
[43]. Considering the importance of cultural compatibility be-
tween psychosocial interventions and patients’ cultural back-
ground, it would be interesting for future research to untangle
if differences in treatment effect size of mindfulness-based
interventions for Western breast cancer patients versus their
counterparts who are Asian descendants who migrated to
Western countries, e.g., North America or Australia.
Although this study revealed an overall large and statisti-
cally significant treatment effect for mindfulness-based inter-
ventions among Chinese breast cancer patients’ physical out-
comes, further analyses suggested that mindfulness-based in-
terventions were effective for sleep-related outcomes (d =
0.94, p < 0.001), fatigue (d = 1.08, p < 0.001) but not for other
physical symptoms (d = 0.59, p = 0.111), like nausea/
vomiting, dizziness, or pain. It is possible that many patients
with intensive symptoms of nausea/vomiting, dizziness, or
pain are still receiving invasive cancer treatment or are
Table 2 Meta-analysis results
Estimates t(df) K/N* 95% CI p value
Overall effect 0.921 16 (43.6) 45/286 [0.805, 1.040] < 0.001
Outcome types
Symptom Outcomes 0.885 8.18 (17.9) 19/82 [0.657, 1.110] < 0.001
Sleep wellness 0.939 8.01 (9.93) 11/36 [0.678, 1.200] < 0.001
Fatigue 1.082 11.6 (4.64) 6/20 [0.833, 1.320] < 0.001
Physical symptoms 0.589 2.04 (3.99) 5/26 [-0.212, 1.390] = 0.111
Psychosocial wellness 0.984 19.1 (34.2) 36/138 [0.879, 1.090] < 0.001
Depression and anxiety 0.971 17 (29.3) 31/65 [0.854, 1.090] < 0.001
General psychology 0.969 12.6 (15.8) 17/73 [0.805, 1.130] < 0.001
Quality of life 0.990 10.5 (8.88) 10/60 [0.776, 1.200] < 0.001
Mindfulness** 0.637 -- 1/6 -- --
Design
RCT 0.942 13.4 (30.7) 32/212 [0.799, 1.080] < 0.001
nRCT 0.870 8.31 (11.9) 13/74 [0.642, 1.100] < 0.001
Current treatment
Chemotherapy only 0.863 10.1 (19.8) 21/159 [0.685, 1.040] < 0.001
Multi-treatment 0.971 12.3 (22.8) 24/127 [0.808, 1.130] < 0.001
Treatment modality
Individual treatment 0.942 11.2 (20.8) 22/151 [0.768, 1.120] < 0.001
Group treatment 0.901 11.1 (21.8) 23/135 [0.733, 1.070] < 0.001
Treatment nature
Psychotherapeutic 0.957 20.1 (32.8) 35/221 [0.860, 1.050] < 0.001
Supportive 0.784 4.12 (8.99) 10/65 [0.353, 1.210] < 0.001
Treatment integrity
Independent intervention 0.904 14.5 (37.6) 39/259 [0.778, 1.030] < 0.001
Combined intervention 1.030 6.71 (4.97) 6/27 [0.638, 1.430] = 0.001
*K, number of studies; N, number of effect sizes
**Mindfulness-related outcomes were only reported by 1 study including 6 effect sizes; therefore, subgroup analysis was not feasible
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recently off treatment. Therefore, the treatment effect of
mindfulness-based interventions may be hindered for these
treatment-related physical symptoms. This finding has impor-
tant practice implications for psycho-oncology providers
when supporting Chinese breast cancer patients for physical
outcomes using mindfulness-based interventions. To improve
patients’ physical outcomes, mindfulness-based interventions
can be regarded as empirically supported interventions for
sleep problems and fatigue but not for other symptoms.
Subgroup analyses further revealed that mindfulness-based
interventions were overall effective among both randomized
controlled trials and controlled trials without random assign-
ment, for breast cancer patients receiving only chemotherapy
and for those receiving multiple treatments, and when deliv-
ered in individual and group formats. Findings revealed that
mindfulness-based interventions were overall effective when
delivered as a psychotherapeutic intervention and as a sup-
portive intervention. Similarly, mindfulness-based interven-
tions were effective when delivered on their own or in con-
junction with other interventions. All of these subgroup anal-
yses further endorsed the effectiveness of mindfulness-based
interventions for Chinese breast cancer patients when being
delivered in a variety of formats, e.g., individual versus group
format or delivered on their own versus in a combined format.
Limitations and recommendation for future research The cur-
rent meta-analysis has several strengths including a compre-
hensive literature search, inclusion of published and gray lit-
erature, a large number of included studies (n = 45), and the
use of advanced statistical methods which allowed meta-
analyzing 286 effect sizes to increase statistical power. A fur-
ther strength was this study’s focus on multiple domains of
outcomes while also conducting subgroup and domain-
specific analyses to deliver findings with informative implica-
tions to clinical practice.
Limitations of this study include the possibility that we
could have missed eligible studies even though we used a
rigorous and comprehensive search process. In addition,
while a set of moderators were tested to account for the
significant amount of heterogeneity across effect sizes,
none of them was identified as a significant moderator.
Third, given the already heavy content of this review, fur-
ther moderator analyses within each outcome domains
were not conducted. Future studies should report on addi-
tional moderator analyses specific to each domains of out-
comes. Finally, this review only included Chinese studies
in the Chinese language, thus preventing formal compari-
son between the Western and Chinese literature. It would
be valuable to have a cross-cultural and interdisciplinary
team to conduct a comparative systematic review and
meta-analysis of the Western and Chinese literature on this
topic to formally compare the treatment effect of
mindfulness-based interventions for breast cancer patients.
Conclusion
The present review, to our knowledge, is the first to synthesize
the effects of mindfulness-based interventions for Chinese
breast cancer patients (and published in Chinese literature)
across domains of outcomes, i.e., physical, psychosocial,
and quality of life outcomes. Results suggest that
mindfulness-based interventions are overall effective for
Chinese breast cancer patients with large treatment effects
across outcome domains except for physical outcomes, e.g.,
nausea/vomiting, dizziness, and pain. These findings have im-
portant implications for psycho-oncology providers when
support ing Chinese breast cancer pat ients using
mindfulness-based interventions. Results also point to similar-
ities and differences of mindfulness-based interventions for
breast cancer patients in the Chinese literature versus the
Western literature, which are important for psycho-oncology
providers supporting Chinese breast cancer patients.
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